Timpani Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-71,529
| Closed | -$4.28M | – | 110 |
|
|
2018
Q2 | $4.28M | Buy |
71,529
+14,028
| +24% | +$840K | 1.26% | 32 |
|
|
2018
Q1 | $2.63M | Buy |
57,501
+12,702
| +28% | +$582K | 0.92% | 48 |
|
|
2017
Q4 | $1.79M | Sell |
44,799
-3,133
| -7% | -$125K | 0.64% | 68 |
|
|
2017
Q3 | $1.92M | Sell |
47,932
-52,776
| -52% | -$2.11M | 0.7% | 65 |
|
|
2017
Q2 | $4.34M | Sell |
100,708
-278
| -0.3% | -$12K | 1.61% | 19 |
|
|
2017
Q1 | $3.16M | Buy |
100,986
+45,653
| +83% | +$1.43M | 1.27% | 31 |
|
|
2016
Q4 | $1.4M | Sell |
55,333
-31,070
| -36% | -$784K | 0.58% | 72 |
|
|
2016
Q3 | $2.14M | Buy |
+86,403
| New | +$2.14M | 0.85% | 49 |
|
|
2014
Q4 | – | Sell |
-156,236
| Closed | -$1.36M | – | 98 |
|
|
2014
Q3 | $1.36M | Buy |
+156,236
| New | +$1.36M | 0.62% | 61 |
|